Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and accelerate clinical development, today announces the opening of its US headquarters in Boston, Massachusetts as part of the company’s international expansion plan. The new office is part of the renowned Cambridge Innovation Center in Kendall Square, which holds the largest concentration of life science companies in the US.
Charlotte Turnier, SVP Sales and Marketing, has relocated from NOVA’s headquarters in Lyon, France to its new US base, where she will lead the company’s sales acceleration plan. NOVA’s US team also includes Jim Bosley, SVP Modeling and Simulation, and Heidi Morris, Business Development Director.
François-Henri Boissel, CEO of NOVA, commented: “The opening of our new facilities in the US marks a major milestone for NOVA and represents an exciting time for the company as we expand our services to our current and future partners in the US and beyond. The state-of-the-art facilities at the Cambridge Innovation Center are the perfect location to foster innovation as we continue to develop our Jinkō® platform. The team at NOVA continues to be the go-to partner for pharma and biotech companies for in silico clinical trial support, and I am excited for what the future holds for NOVA.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!